TY - JOUR AU - HEYMANN, R. E. AU - PAIVA, E. AU - HELFENSTEIN, M. AU - POLLAK, D. AU - MARTINEZ, J. AU - PROVENZA, J. R. PY - 2010 DA - 2010// TI - Brazilian consensus on the treatment of fibromyalgia JO - Brazilian J Rheumatol VL - 50 UR - https://doi.org/10.1590/S0482-50042010000100006 DO - 10.1590/S0482-50042010000100006 ID - HEYMANN2010 ER - TY - STD TI - QUEIROZ LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. Available from https://doi.org/10.1007/s11916-013-0356-5. Accessed 18 Mar 2019. ID - ref2 ER - TY - STD TI - SENNA ER, PEREIRA VB, CICONELLI RM, FERRAZ MB. Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach. J Rheumatol. 2020:5 Available from: http://www.jrheum.org/content/31/3/594. UR - http://www.jrheum.org/content/31/3/594 ID - ref3 ER - TY - STD TI - CHAKR R, Xavier R. Fibromyalgia: practical principles that assist in the indication and adjustment of drug treatment. J Bras Med. 2014;102(6) [cited 2019 Mar 31]. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/lil-737128. UR - https://pesquisa.bvsalud.org/portal/resource/pt/lil-737128 ID - ref4 ER - TY - JOUR AU - HÄUSER, W. AU - BERNARDY, K. AU - ÜÇEYLER, N. AU - Sommer, C. PY - 2009 DA - 2009// TI - Treatment of fibromyalgia syndrome with antidepressants: A meta-analysis JO - JAMA VL - 301 UR - https://doi.org/10.1001/jama.2008.944 DO - 10.1001/jama.2008.944 ID - HÄUSER2009 ER - TY - JOUR AU - ROSKELL, N. S. AU - BEARD, S. AU - ZHAO, Y. AU - KIM LE TK. PY - 2011 DA - 2011// TI - A meta-analysis of pain response in the treatment of fibromyalgia. Meta-analysis of fibromyalgia treatments JO - Pain Pract VL - 11 UR - https://doi.org/10.1111/j.1533-2500.2010.00441.x DO - 10.1111/j.1533-2500.2010.00441.x ID - ROSKELL2011 ER - TY - JOUR AU - ROBINSON, R. L. AU - JONES, M. L. PY - 2006 DA - 2006// TI - In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review JO - Expert Opin Pharmacother VL - 7 UR - https://doi.org/10.1517/14656566.7.8.1027 DO - 10.1517/14656566.7.8.1027 ID - ROBINSON2006 ER - TY - STD TI - HORSLEY W. Cost comparison charts. RDTC. 2020;78. Available from: http://gmmmg.nhs.uk/docs/cost_comparison_charts.pdf. [cited 2020 Jun 05]. UR - http://gmmmg.nhs.uk/docs/cost_comparison_charts.pdf ID - ref8 ER - TY - STD TI - RICHARDSON J, Schlander M. Health technology assessment (HTA) and economic evaluation: efficiency or fairness first. Journal of Market Access & Health Policy. 2019;7(1):1557981. https://doi.org/10.1080/20016689.2018.1557981. ID - ref9 ER - TY - JOUR AU - BOUGIOUKAS, K. I. AU - LIAKOS, A. AU - TSAPAS, A. AU - NTZANI, E. AU - Haidich, A. PY - 2018 DA - 2018// TI - Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms JO - J Clin Epidemiol VL - 93 UR - https://doi.org/10.1016/j.jclinepi.2017.10.002 DO - 10.1016/j.jclinepi.2017.10.002 ID - BOUGIOUKAS2018 ER - TY - JOUR AU - HUNT, H. AU - POLLOCK, A. AU - CAMPBELL, P. AU - ESTCOURT, L. AU - BRUNTON, G. PY - 2018 DA - 2018// TI - An introduction to overviews of reviews: planning a relevant research question and objective for an overview JO - Syst Rev VL - 7 UR - https://doi.org/10.1186/s13643-018-0695-8 DO - 10.1186/s13643-018-0695-8 ID - HUNT2018 ER - TY - CHAP AU - BECKER, L. A. AU - Oxman, A. D. ED - Higgins, J. P. T. ED - Green, S. PY - 2011 DA - 2011// TI - Chapter 22: overviews of reviews BT - Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated march 2011]. The Cochrane collaboration UR - https://doi.org/10.1002/9780470712184.ch22 DO - 10.1002/9780470712184.ch22 ID - BECKER2011 ER - TY - STD TI - SHEA BJ, REEVES BC, WELLS G, THUKU M, HAMEL C, MORAN J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both. BMJ. 2017;j4008. https://doi.org/10.1136/bmj.j4008. ID - ref13 ER - TY - STD TI - SCHÜNEMANN H, BROZEK J, GUYATT G, OXMAN A. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE working group; 2013. Available from: guidelinedevelopment.org/handbook. UR - https://guidelinedevelopment.org/handbook ID - ref14 ER - TY - BOOK PY - 2015 DA - 2015// TI - GRADEpro guideline development tool [software] ID - ref15 ER - TY - JOUR AU - PIEPER, D. AU - Antoine, S. -. L. AU - MATHES, T. AU - NEUGEBAUER, E. A. M. AU - EIKERMANN, M. PY - 2014 DA - 2014// TI - Systematic review finds overlapping reviews were not mentioned in every other overview JO - J Clin Epidemiol VL - 67 UR - https://doi.org/10.1016/j.jclinepi.2013.11.007 DO - 10.1016/j.jclinepi.2013.11.007 ID - PIEPER2014 ER - TY - STD TI - FARAG H, YUNUSA I, GOSWAMI H, SULTAN I, DOUCETTE J, Eguale T. Effectiveness and acceptability of amitriptyline and food and drug administration – approved treatments for fibromyalgia: a network meta-analysis [abstract]. Value Health. 2020;23(supplement 1). https://doi.org/10.1016/j.jval.2020.04.693. ID - ref17 ER - TY - STD TI - THORPE J, SHUM B, MOORE RA, WIFFEN PJ, GILRON I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Pain, Palliative and Supportive Care Group, editor. Cochrane database of systematic reviews. 2018. Available from: https://doi.org/10.1002/14651858.CD010585.pub2. [cited 2019 May 26]. ID - ref18 ER - TY - JOUR AU - SOMMER, C. AU - ALTEN, R. AU - K-J, B. Ä. R. AU - BERNATECK, M. AU - BRÜCKLE, W. AU - FRIEDEL, E. PY - 2017 DA - 2017// TI - Drug therapy of fibromyalgia syndrome. Updated guidelines 2017 and overview of systematic review articles JO - Schmerz VL - 31 UR - https://doi.org/10.1007/s00482-017-0207-0 DO - 10.1007/s00482-017-0207-0 ID - SOMMER2017 ER - TY - BOOK AU - SMITH, B. AU - Peterson, K. AU - Fu, R. AU - McDonagh, M. AU - Thakurta, S. PY - 2011 DA - 2011// TI - Drug class review: drugs for fibromyalgia: final original report PB - Science University CY - Portland ID - SMITH2011 ER - TY - JOUR AU - HÄUSER, W. AU - PETZKE, F. AU - ÜÇEYLER, N. AU - SOMMER, C. PY - 2011 DA - 2011// TI - Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta- analysis JO - Rheumatology VL - 50 UR - https://doi.org/10.1093/rheumatology/keq354 DO - 10.1093/rheumatology/keq354 ID - HÄUSER2011 ER - TY - JOUR AU - ÜÇEYLER, N. AU - HÄUSER, W. AU - Sommer, C. PY - 2008 DA - 2008// TI - A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.24000 DO - 10.1002/art.24000 ID - ÜÇEYLER2008 ER - TY - JOUR AU - PERROT, S. AU - R-M, J. A. V. I. E. R. AU - MARTY, M. AU - JEUNNE, C. AU - LAROCHE, F. PY - 2008 DA - 2008// TI - Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies JO - Rheumatology VL - 47 UR - https://doi.org/10.1093/rheumatology/ken110 DO - 10.1093/rheumatology/ken110 ID - PERROT2008 ER - TY - JOUR AU - MACFARLANE, G. J. AU - KRONISCH, C. AU - DEAN, L. E. AU - ATZENI, F. AU - HÄUSER, W. AU - Fiub, E. PY - 2017 DA - 2017// TI - EULAR revised recommendations for the management of fibromyalgia JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2017-211587 DO - 10.1136/annrheumdis-2017-211587 ID - MACFARLANE2017 ER - TY - JOUR AU - M-A, F. I. T. Z. C. H. A. R. L. E. S. AU - STE-MARIE, P. A. AU - GOLDENBERG, D. L. AU - PEREIRA, J. X. AU - ABBEY, S. AU - CHOINIÈRE, M. PY - 2013 DA - 2013// TI - 2012 Canadian guidelines for the diagnosis and Management of Fibromyalgia Syndrome: executive summary JO - Pain Res Manag VL - 18 UR - https://doi.org/10.1155/2013/918216 DO - 10.1155/2013/918216 ID - M-A2013 ER - TY - JOUR AU - ROSSY, L. A. AU - BUCKELEW, S. P. AU - DORR, N. AU - HAGGLUND, K. J. AU - THAYER, J. F. AU - MCINTOSH, M. J. PY - 1999 DA - 1999// TI - A meta-analysis of fibromyalgia treatment interventions JO - Ann Behav Med VL - 21 UR - https://doi.org/10.1007/bf02908299 DO - 10.1007/bf02908299 ID - ROSSY1999 ER - TY - JOUR AU - SLUKA, K. A. AU - Clauw, D. J. PY - 2016 DA - 2016// TI - Neurobiology of fibromyalgia and chronic widespread pain JO - Neuroscience VL - 338 UR - https://doi.org/10.1016/j.neuroscience.2016.06.006 DO - 10.1016/j.neuroscience.2016.06.006 ID - SLUKA2016 ER - TY - JOUR AU - ROIZENBLATT, S. AU - NETO, N. S. R. AU - Tufik, S. PY - 2011 DA - 2011// TI - Sleep disorders and fibromyalgia JO - Curr Pain Headache Rep VL - 15 UR - https://doi.org/10.1007/s11916-011-0213-3 DO - 10.1007/s11916-011-0213-3 ID - ROIZENBLATT2011 ER - TY - STD TI - LIMA MLA, MUNUERA A, PEIXOTO D, GUIMARÃES M, SILVA C. The prevalence of depression in fibromyalgia syndrome. Int J Psychiatry. 2016;21(6). Available from: https://www.polbr.med.br/ano16/art0616.php. [cited 2019 Jul 25]. UR - https://www.polbr.med.br/ano16/art0616.php ID - ref29 ER - TY - JOUR AU - BAKER, K. AU - Barkhuizen, A. PY - 2005 DA - 2005// TI - Pharmacologic treatment of fibromyalgia JO - Curr Pain Headache Rep VL - 9 UR - https://doi.org/10.1007/s11916-005-0003-x DO - 10.1007/s11916-005-0003-x ID - BAKER2005 ER - TY - JOUR AU - DUENAS, M. AU - OJEDA, B. AU - SALAZAR, A. AU - MICO, J. A. AU - Failde, I. PY - 2016 DA - 2016// TI - A review of chronic pain impact on patients, their social environment and the health care system JO - JPR VL - 9 UR - https://doi.org/10.2147/JPR.S105892 DO - 10.2147/JPR.S105892 ID - DUENAS2016 ER - TY - JOUR PY - 2015 DA - 2015// TI - American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults JO - J Am Geriatr Soc VL - 63 UR - https://doi.org/10.1001/archinte.164.3.298 DO - 10.1001/archinte.164.3.298 ID - ref32 ER - TY - JOUR AU - BIDARI, A. AU - PARSA, B. G. AU - GHALEHBAGHI, B. PY - 2018 DA - 2018// TI - Challenges in fibromyalgia diagnosis : from meaning of symptoms to fibromyalgia labeling JO - Korean J Pain VL - 31 UR - https://doi.org/10.3344/kjp.2018.31.3.147 DO - 10.3344/kjp.2018.31.3.147 ID - BIDARI2018 ER - TY - STD TI - POLLOCK A, CAMPBELL P, HUNT H, ESTCOURT L, Brunton G. Selecting and implementing overview methods: implications from five exemplary overviews. Syst Rev. 2017Available from. https://doi.org/10.1186/s13643-017-0534-3. ID - ref34 ER - TY - STD TI - LI G, BHATT M, WANG M, MBUAGBAW L, SAMAAN Z, THABANE L. Enhancing primary reports of randomized controlled trials: three most common challenges and suggested solutions. Proc Natl Acad Sci. 2018;115(11):2595–9. Available from: https://doi.org/10.1073/pnas.1708286114. ID - ref35 ER -